高血糖与银屑病炎症相关:人类与小鼠研究
该研究探讨银屑病与高血糖的相关性。患者中银屑病严重程度与高血糖水平相关,光疗改善胰岛素分泌;咪喹莫特诱导的小鼠银屑病样炎症也导致高血糖,抗IL-17A单抗改善患者和小鼠的高血糖。
要点
- 银屑病严重程度与高血糖水平相关。
- 光疗改善银屑病患者的胰岛素分泌。
- 抗IL-17A单抗改善银屑病相关高血糖。
核心结论
- 高血糖与银屑病高度相关,主要经由IL-17介导。
研究设计与样本
- 研究纳入银屑病患者和小鼠模型,小鼠经咪喹莫特诱导银屑病样炎症。
主要发现
- 患者银屑病严重程度与高血糖水平相关。
- 光疗治疗银屑病改善胰岛素分泌。
- 咪喹莫特处理小鼠出现高血糖和胰岛素分泌受损,无显著胰岛炎症。
- 抗IL-17A单抗改善患者和咪喹莫特处理小鼠的高血糖。
临床怎么用
- 银屑病患者应关注血糖水平。
- 抗IL-17A治疗可能改善银屑病相关高血糖。
局限性
- 尚需确定银屑病样皮肤炎症单独是否能诱导高血糖。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic low-grade inflammation can cause several metabolic syndromes. Patients with psoriasis, a chronic immunological skin inflammation, often develop diabetes. However, it is not clear to date how psoriasis leads to, or is correlated with, glucose intolerance. Here, we investigate whether psoriasis itself is correlated with hyperglycemia in humans and mice. In patients, the severity of psoriasis was correlated with high blood glucose levels, and treatment of psoriasis by phototherapy improved insulin secretion. Imiquimod-induced systemic and cutaneous inflammation in mice, with features of human psoriasis, also resulted in hyperglycemia. Although it should be determined if psoriasis-like cutaneous inflammation alone can induce hyperglycemia, imiquimod-treated mice showed impairment of insulin secretion without significant islet inflammation. Administration of anti-IL-17A monoclonal antibody improved hyperglycemia in patients with psoriasis and imiquimod-treated mice with psoriasiform features. These results suggest that hyperglycemia is highly associated with psoriasis, mainly through IL-17.
引用
- Ikumi K, Odanaka M, Shime H, et al. Hyperglycemia Is Associated with Psoriatic Inflammation in Both Humans and Mice. J Invest Dermatol. 2019. PMID: 30776434. doi:10.1016/j.jid.2019.01.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。